|
[µ¥Àϸ®¸Þµð Á¤¼÷°æ ±âÀÚ] ÇѾç´ëº´¿ø(¿øÀå À̱¤Çö)Àº ¿À´Â 10¿ù6ÀÏ Àǰú´ëÇÐ º»°ü 6Ãþ TBL½Ç¿¡¼ ‘Á¦5ȸ ¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö’À» °³ÃÖÇÑ´Ù°í 27ÀÏ ¹àÇû´Ù.
ÅÂ°æ ¾Ï¼¾ÅÍ ¼ÒÀåÀº "´ÙÇÐÁ¦ Çù·ÂÁø·á µîÀ» ÅëÇØ ¾ÏȯÀÚ Ä¡·á¿¡ ÃÖ¼±À» ´ÙÇÏ¸é¼ ¸Å³â ½ÉÆ÷Áö¾öÀ» °³ÃÖÇϰí ÀÖ´Ù"¸ç "À̹ø ½ÉÆ÷Áö¾ö¿¡¼´Â ¾Ï Ä¡·á¿¡¼ Â÷¼¼´ë ¿°±â¼¿ ºÐ¼®¹ýÀ» ÁÖÁ¦·Î ÁøÇàµÈ´Ù"°í ¹àÇû´Ù.
Çà»ç¿¡¼´Â ÀΰøÁö´É(AI) ¿Ó½¼ µîÀÇ ¹ßÇ¥°¡ À̾îÁö¸ç ºòµ¥ÀÌÅÍ °ü·Ã, ¼®ÇеéÀÇ °¿¬µµ ÆîÃÄÁ® ÃֽаæÇèÀÌ °øÀ¯µÉ ¿¹Á¤ÀÌ´Ù.
½ÉÆ÷Áö¾öÀº ÃÑ 3°³ ¼¼¼ÇÀ¸·Î ±¸¼ºµÆÀ¸¸ç ù ¹øÂ° ¼¼¼ÇÀº ÇѾç´ëº´¿ø ±Ç¼ºÁØ ±³¼ö(¿Ü°ú)¿Í ±èµ¿¼± ±³¼ö(³»ºÐºñ´ë»ç³»°ú) ±³¼ö°¡ ÁÂÀåÀ» ¸Ã¾Ò´Ù.
¼Û¿µ¼ö ±³¼ö(º´¸®°ú)°¡ ‘Bioinfomatics & NGS’, ±è¿µÀº ±³¼ö(Áø´Ü°Ë»çÀÇÇаú)°¡ ‘Hereditary cancer syndrome’, ½Å¼öÁø ±³¼ö(º´¸®°ú)°¡ ‘Clinical application of NGS’¸¦ ÁÖÁ¦·Î °ÀÇÇÒ ¿¹Á¤ÀÌ´Ù.
µÎ ¹øÂ° ¼¼¼ÇÀº Á¤¿ø»ó ±³¼ö(ÈäºÎ¿Ü°ú)¿Í ÀÌ¿µÈ£ ±³¼ö(¼Ò¾ÆÃ»¼Ò³â°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ¹éÁ¤Èì °¡Ãµ´ë ±æº´¿ø ±³¼ö°¡ ‘MDT with Watson for Oncology in Solid Tumor’, ÀÌÀ¯¶ó ¼¿ï¾Æ»êº´¿ø ±³¼ö°¡ ‘Information technology for predictive, preventive, personalized and participatory medicine’¸¦ ÁÖÁ¦·Î ¹ßÇ¥ÇÑ´Ù. |